Archive · 30 Jun 2025
Axis Securities Recommends Healthcare Global Shares for 10% Upside
Imagine a healthcare company, Healthcare Global Enterprises (HCG), that specializes in cancer treatment.
An investment firm thinks the company's stock price could go up!
They base their prediction on the company's strong performance and plans to open new centers and treat more patients.
HCG recently made a big acquisition and are adding more beds.
If you want to invest in shares in the company, the firm believes now may be a good time to buy.
Axis Securities recommends Healthcare Global Enterprises (HCG) shares for a potential 10% gain.
HCG operates 21 cancer care centers and is expanding its capacity.
HCG's revenue grew 18.3% in Q4FY25, with improved occupancy rates.
The company acquired MG Hospital in Vizag and is adding beds in North Bangalore.
HCG aims to increase digital channel revenue to 25% over the next 3-5 years.
- Who
- Healthcare Global Enterprises, Axis Securities.
- What
- Axis Securities recommends buying Healthcare Global Enterprises (HCG) shares.
- When
- Recently, with a focus on Q4FY25 performance and future growth.
- Where
- India
- Why
- Due to strong operational efficiency, capacity expansion, and sectoral tailwinds.
Risks and Considerations
Company Strengths
Market Volatility vs Growth potential
Risks and Considerations
Potential volatility due to market conditions
Company Strengths
Strong financials and expansion plans
- Company
- Healthcare Global Enterprises (HCG)
- Target Price
- ₹600
- Current Price (approx)
- ₹544
- Potential Gain
- 10%
- Revenue Growth (Q4FY25)
- 18.3%
- Occupancy Increase (YoY)
- 310 bps
- EBITDA Margin (Q4FY25)
- 18.1%
